Clinical application of targeted next-generation sequencing in pneumonia diagnosis among cancer patients
tNGS demonstrates higher sensitivity and a broader pathogen detection spectrum compared to CMT, making it a valuable diagnostic tool for managing pneumonia in cancer patients.
Authors
- Cuiyun Zhang (ORCID: https://orcid.org/0000-0002-0490-8978)
- Jie Ma (ORCID: https://orcid.org/0000-0001-5346-8457)
- Yongjun Guo (ORCID: https://orcid.org/0000-0003-1641-2969)
- Jiuzhou Zhao (ORCID: https://orcid.org/0000-0001-6292-6392)
- Zhizhong Wang (ORCID: https://orcid.org/0000-0002-2967-811X)
- Weizhen Wang (ORCID: https://orcid.org/0000-0002-0798-1935)
- Dejian Gu
- Yang Ke (ORCID: https://orcid.org/0000-0001-5148-3370)
- Rui Sun (ORCID: https://orcid.org/0000-0003-3537-2990)
- Chengzhi Zhao (ORCID: https://orcid.org/0000-0002-4880-8223)
- Bing Wei (ORCID: https://orcid.org/0000-0002-3475-7509)
- Tingjie Wang (ORCID: https://orcid.org/0000-0001-9238-0968)
- Hao Liu (ORCID: https://orcid.org/0000-0002-2366-9554)
Institutions
- Zhengzhou University (CN)
- Annoroad Gene Technology (China) (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-02-18
- DOI
- https://doi.org/10.3389/fcimb.2025.1497198
- Citations
- 6
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 9.11